Other · developed by Eli Lilly and Company
P450 (CYP450) is a family of cytochrome enzymes involved in electron transport and the oxidative metabolism of drugs and other bioactive molecules. A CYP450 drug cocktail of caffeine, midazolam, flurbiprofen, dextromethorphan and omeprazole is administered orally in a study in amyotrophic lateral sclerosis.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07883590 | Phase 1 | Amyotrophic Lateral Sclerosis | Not yet recruiting | LLY |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Amyotrophic Lateral SclerosisCytochrome P-450 Enzyme System
Updated Nov 1, 2026. Something wrong or missing? Report it on the LLY page.
See LLY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
LLY catalysts and pipeline →